54. PREDICTION OF ANTIPSYCHOTIC-INDUCED METABOLIC ADVERSE EFFECTS USING MULTIMODAL ARTIFICIAL INTELLIGENCEKhushbu Agarwal, Ayman H. Fanous, Colby Ham et al.|European Neuropsychopharmacology|2024Cited by 1
89. PHARMACOGENOMICS AND PHARMACOTRANSCRIPTOMICS OF ANTIPSYCHOTIC-INDUCED HYPERCHOLESTEROLEMIA IN 58,000 VETERANSHamed Kazemi, Ayman H. Fanous, John H. Drake et al.|European Neuropsychopharmacology|2025Cited by 0